Geyan Wu

1.6k total citations · 1 hit paper
29 papers, 1.1k citations indexed

About

Geyan Wu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Geyan Wu has authored 29 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 20 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Geyan Wu's work include MicroRNA in disease regulation (9 papers), RNA modifications and cancer (9 papers) and Epigenetics and DNA Methylation (7 papers). Geyan Wu is often cited by papers focused on MicroRNA in disease regulation (9 papers), RNA modifications and cancer (9 papers) and Epigenetics and DNA Methylation (7 papers). Geyan Wu collaborates with scholars based in China, Australia and Germany. Geyan Wu's co-authors include Jinrong Zhu, Libing Song, Jun Li, Lixue Cao, Zhanyao Tan, Xin Zhang, Aibin Liu, Shuxia Zhang, Lili Jiang and Miaoling Tang and has published in prestigious journals such as Nature Communications, Cancer Research and Oncogene.

In The Last Decade

Geyan Wu

28 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ferroptosis: Emerging mechanisms, biological function, and therapeutic potential in cancer and inflammation

2024 77 citations Xin Jin, Xiangyu Qiu et al. Cell Death Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Geyan Wu China	21	849	568	179	160	135	29	1.1k
Shengni Hua China	16	829 1.0×	587 1.0×	253 1.4×	122 0.8×	76 0.6×	22	1.1k
Longchang Jiang Germany	8	674 0.8×	622 1.1×	350 2.0×	102 0.6×	139 1.0×	14	1.1k
Lishan Fang China	16	1.2k 1.4×	870 1.5×	265 1.5×	101 0.6×	108 0.8×	27	1.5k
Liyan Lv China	15	1.0k 1.2×	913 1.6×	233 1.3×	185 1.2×	139 1.0×	21	1.4k
Mingo M. H. Yung Hong Kong	18	874 1.0×	566 1.0×	293 1.6×	245 1.5×	222 1.6×	23	1.3k
Xianhui Ruan China	16	647 0.8×	332 0.6×	262 1.5×	138 0.9×	101 0.7×	63	982
Yanxia Lu China	19	1.0k 1.2×	843 1.5×	194 1.1×	109 0.7×	110 0.8×	28	1.3k
Dongdong Tong China	20	805 0.9×	574 1.0×	112 0.6×	93 0.6×	73 0.5×	44	1000
Yuxiang Fang China	16	854 1.0×	659 1.2×	201 1.1×	235 1.5×	67 0.5×	27	1.1k
Bo Yin China	19	573 0.7×	330 0.6×	219 1.2×	169 1.1×	139 1.0×	43	873

Countries citing papers authored by Geyan Wu

Since Specialization

Citations

This map shows the geographic impact of Geyan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geyan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geyan Wu more than expected).

Fields of papers citing papers by Geyan Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geyan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geyan Wu. The network helps show where Geyan Wu may publish in the future.

Co-authorship network of co-authors of Geyan Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Geyan Wu. A scholar is included among the top collaborators of Geyan Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geyan Wu. Geyan Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ou, S.-H.I., Xiangyu Qiu, Xin Jin, et al.. (2025). Deciphering the mechanisms of long non-coding RNAs in ferroptosis: insights into its clinical significance in cancer progression and immunology. Cell Death Discovery. 11(1). 14–14. 3 indexed citations

Tang, Miaoling, et al.. (2025). A microprotein encoded by LINC00263 promotes breast cancer osteolytic bone metastasis by inducing osteoclastogenesis and inhibiting osteoclast ferroptosis. Oncogene. 44(26). 2201–2216. 1 indexed citations

Zhang, Shuxia, Xincheng Li, Xingui Wu, et al.. (2024). Dynamic structural remodeling of LINC01956 enhances temozolomide resistance in MGMT -methylated glioblastoma. Science Translational Medicine. 16(767). eado1573–eado1573. 5 indexed citations

Jin, Xin, Xiangyu Qiu, S.-H.I. Ou, et al.. (2024). Ferroptosis: Emerging mechanisms, biological function, and therapeutic potential in cancer and inflammation. Cell Death Discovery. 10(1). 45–45. 77 indexed citations breakdown →

Zhang, Qiangnu, Chu‐Li Fu, Zuotian Huang, et al.. (2024). CSTF2 Supports Hypoxia Tolerance in Hepatocellular Carcinoma by Enabling m6A Modification Evasion of PGK1 to Enhance Glycolysis. Cancer Research. 85(3). 515–534. 4 indexed citations

Zhu, Jinrong, Xiangyu Qiu, Xin Jin, et al.. (2024). ZNF468-mediated epigenetic upregulation of VEGF-C facilitates lymphangiogenesis and lymphatic metastasis in ESCC via PI3K/Akt and ERK1/2 signaling pathways. Cellular Oncology. 47(5). 1927–1942.

Tang, Miaoling, Meisongzhu Yang, Geyan Wu, et al.. (2021). Epigenetic Induction of Mitochondrial Fission Is Required for Maintenance of Liver Cancer–Initiating Cells. Cancer Research. 81(14). 3835–3848. 52 indexed citations

Wu, Geyan, Peng Hu, Miaoling Tang, et al.. (2021). ZNF711 down-regulation promotes CISPLATIN resistance in epithelial ovarian cancer via interacting with JHDM2A and suppressing SLC31A1 expression. EBioMedicine. 71. 103558–103558. 51 indexed citations

Zhu, Jinrong, Geyan Wu, Libing Song, et al.. (2019). NKX2-8 deletion-induced reprogramming of fatty acid metabolism confers chemoresistance in epithelial ovarian cancer. EBioMedicine. 43. 238–252. 47 indexed citations

10.

Cao, Lixue, Geyan Wu, Jinrong Zhu, et al.. (2019). Genotoxic stress-triggered β-catenin/JDP2/PRMT5 complex facilitates reestablishing glutathione homeostasis. Nature Communications. 10(1). 3761–3761. 41 indexed citations

11.

Wu, Geyan, Libing Song, Jinrong Zhu, et al.. (2018). An ATM/TRIM37/NEMO Axis Counteracts Genotoxicity by Activating Nuclear-to-Cytoplasmic NF-κB Signaling. Cancer Research. 78(22). 6399–6412. 36 indexed citations

12.

Wu, Geyan, Lixue Cao, Jinrong Zhu, et al.. (2018). Loss of RBMS3 Confers Platinum Resistance in Epithelial Ovarian Cancer via Activation of miR-126-5p/β-catenin/CBP signaling. Clinical Cancer Research. 25(3). 1022–1035. 45 indexed citations

13.

Tan, Zhanyao, Libing Song, Yanqing Zhou, et al.. (2018). TRIM14 promotes chemoresistance in gliomas by activating Wnt/β-catenin signaling via stabilizing Dvl2. Oncogene. 37(40). 5403–5415. 64 indexed citations

14.

Zhu, Jinrong, Geyan Wu, Zunfu Ke, et al.. (2018). Targeting TRIM3 deletion-induced tumor-associated lymphangiogenesis prohibits lymphatic metastasis in esophageal squamous cell carcinoma. Oncogene. 38(15). 2736–2749. 20 indexed citations

15.

Tan, Zhanyao, Kun Chen, Yanqing Zhou, et al.. (2018). Overexpression of HOXC10 promotes angiogenesis in human glioma via interaction with PRMT5 and upregulation of VEGFA expression. Theranostics. 8(18). 5143–5158. 66 indexed citations

16.

Song, Junwei, Chan Xie, Lili Jiang, et al.. (2018). Transcription factor AP-4 promotes tumorigenic capability and activates the Wnt/β-catenin pathway in hepatocellular carcinoma. Theranostics. 8(13). 3571–3583. 73 indexed citations

17.

Liu, Aibin, Jinrong Zhu, Geyan Wu, et al.. (2017). Antagonizing miR-455-3p inhibits chemoresistance and aggressiveness in esophageal squamous cell carcinoma. Molecular Cancer. 16(1). 106–106. 68 indexed citations

18.

Jiang, Lili, Liang Yu, Xin Zhang, et al.. (2016). miR-892b Silencing Activates NF-κB and Promotes Aggressiveness in Breast Cancer. Cancer Research. 76(5). 1101–1111. 67 indexed citations

19.

Zhang, Xin, Junling Liu, Dan Zang, et al.. (2015). Upregulation of miR-572 transcriptionally suppresses SOCS1 and p21 and contributes to human ovarian cancer progression. Oncotarget. 6(17). 15180–15193. 50 indexed citations

20.

Jiang, Lili, Chanjuan Wang, Fangyong Lei, et al.. (2015). miR-93 Promotes Cell Proliferation in Gliomas through Activation of PI3K/Akt Signaling Pathway. Oncotarget. 6(10). 8286–8299. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact